Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms

Cancer

Volumn 85, Issue 10, 1999, Pages 2138-2143

  Niiyama, Hideaki ^a   Mizumoto, Kazuhiro ^a   Kusumoto, Masahiro ^a   Ogawa, Takahiro ^a   Suehara, Nobuhiro ^a   Shimura, Hideo ^b   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Bile; Bile duct carcinoma; Bile duct neoplasms; Endoscopic retrograde cholangiography; Gallbladder carcinoma; Percutaneous transhepatic cholangioscopy; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BILE; BILE DUCTS; BILIARY TRACT NEOPLASMS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DNA PRIMERS; ENZYME ACTIVATION; ENZYME TESTS; HUMANS; MOLECULAR SEQUENCE DATA; PREDICTIVE VALUE OF TESTS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033562846     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990515)85:10<2138::AID-CNCR7>3.0.CO;2-8     Document Type: Article

References (19)

1. Anderson JB, Cooper MJ, Williamson RC. Adenocarcinoma of the extrahepatic biliary tree. Ann R Coll Surg Engl 1985; 67:139-43.
2. Washington K, Gottfried MR. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 1996;16: 99-104.
3. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996;27:360-5.
4. Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, et al. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 1996;43:521-6.
5. Lee CS, Pirdas A. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 1995;27:117-20.
6. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 1996;38:426-9.
7. Saetta A, Lazaris AC, Davaris PS. Detection of ras oncogene point mutations and simultaneous proliferative fraction estimation in gallbladder cancer. Pathol Res Pract 1996;192: 532-40.
8. Imai M, Hoshino T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994;73: 2727-33.
9. Itoi T, Watanabe H, Ajioka Y, Oohashi Y, Takei K, Nishikura K, et al. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gallbladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol Int 1996;46:333-40.
10. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-6.
11. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
12. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
13. Hiyama K, Hirai Y, Koizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
14. Mizumoto K, Suehara N, Muta T, Kitajima S, Hamasaki N, Tominaga Y, et al. Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma. J Gastroenterol 1996; 31:894-7.
15. Suehara N, Mizumoto K, Muta T, Tominaga Y, Shimura H, Kitajima S, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathologic states. Clin Cancer Res 1997;3:993-8.
16. Suehara N, Mizumoto K, Tanaka M, Niiyama H, Yokohata K, Tominaga Y, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis, Clin Cancer Res 1997;3:2479-83.
17. Kim NW, Piatyszek MA, Prowse KR, Harley CR, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-5.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
19. Sagawa H, Tazuma S, Kajiyama G. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am J Physiol 1993;264: 835-9.